1. Home
  2. ELEV

ELEV

Elevation Oncology Inc. Common stock

Logo Elevation Oncology Inc. Common stock

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Founded: 2019 Country:
N/A
Employees: N/A City: BOSTON
Market Cap: 240.3M IPO Year: 2021
Target Price: $7.25 AVG Volume (30 days): 1.2M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.34 EPS Growth: N/A
52 Week Low/High: $0.36 - $5.89 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: